These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8777581)

  • 1. Prostaglandin I receptor and prostaglandin D receptor.
    Hirata M; Ushikubi F; Narumiya S
    J Lipid Mediat Cell Signal; 1995 Oct; 12(2-3):393-404. PubMed ID: 8777581
    [No Abstract]   [Full Text] [Related]  

  • 2. Specificity between the anti-aggregatory actions of prostacyclin, prostaglandin E1 and D2 on platelets.
    Whittle BJ; Hamid S; Lidbury P; Rosam AC
    Adv Exp Med Biol; 1985; 192():109-25. PubMed ID: 2871707
    [No Abstract]   [Full Text] [Related]  

  • 3. Desensitization of prostacyclin responsiveness in platelets. Apparent differences in the mechanism in vitro or in vivo.
    MacDermot J
    Biochem Pharmacol; 1986 Aug; 35(16):2645-9. PubMed ID: 2427086
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
    Eggerman TL; Harker LA; Andersen NH; Wilson CH
    Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of the platelet prostaglandin D2 receptor. Loss of prostaglandin D2 receptors in platelets of patients with myeloproliferative disorders.
    Cooper B; Ahern D
    J Clin Invest; 1979 Aug; 64(2):586-90. PubMed ID: 222813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desacetyl-1-nantradol: a selective prostaglandin antagonist.
    Horne WC
    Prostaglandins Leukot Med; 1984 Jul; 15(1):129-36. PubMed ID: 6147860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive antagonism at thromboxane receptors in human platelets.
    Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
    Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin D2: a neuromodulator.
    Hayaishi O
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():333-7. PubMed ID: 6221610
    [No Abstract]   [Full Text] [Related]  

  • 10. The binding of 6-oxo-prostaglandin E1 to platelet prostanoid receptors.
    Jaschonek K; Renn W; Weisenberger H
    Prostaglandins Leukot Med; 1986 Sep; 24(1):79-86. PubMed ID: 3020591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinities, selectivities, potencies, and intrinsic activities of natural and synthetic prostanoids using endogenous receptors: focus on DP class prostanoids.
    Sharif NA; Crider JY; Xu SX; Williams GW
    J Pharmacol Exp Ther; 2000 May; 293(2):321-8. PubMed ID: 10772998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for distinct prostaglandin I2 and D2 receptors in human platelets.
    Miller OV; Gorman RR
    J Pharmacol Exp Ther; 1979 Jul; 210(1):134-40. PubMed ID: 221643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transduction coupled to prostaglandin D2.
    Ito S; Negishi M; Sugama K; Okuda-Ashitaka E; Hayaishi O
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():371-4. PubMed ID: 1705384
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostacyclin stimulation of the activation of blood coagulation factor X by platelets.
    Dutta-Roy AK; Ray TK; Sinha AK
    Science; 1986 Jan; 231(4736):385-8. PubMed ID: 3001935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostacyclin and prostaglandin E1: molecular mechanisms and therapeutic utility.
    Kerins DM; Murray R; FitzGerald GA
    Prog Hemost Thromb; 1991; 10():307-37. PubMed ID: 1848945
    [No Abstract]   [Full Text] [Related]  

  • 17. Stimulation of prostaglandin D2 receptors on human platelets by analogs of prostacyclin.
    Alvarez R; Eglen RM; Chang LF; Bruno JJ; Artis DR; Kluge AF; Whiting RL
    Prostaglandins; 1991 Aug; 42(2):105-19. PubMed ID: 1775633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (5Z)-carbacyclin discriminates between prostacyclin-receptors coupled to adenylate cyclase in vascular smooth muscle and platelets.
    Corsini A; Folco GC; Fumagalli R; Nicosia S; Noe MA; Oliva D
    Br J Pharmacol; 1987 Jan; 90(1):255-61. PubMed ID: 3545351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonist regulation of the human platelet prostaglandin D2 receptor.
    Cooper B
    Life Sci; 1979 Oct; 25(16):1361-7. PubMed ID: 230401
    [No Abstract]   [Full Text] [Related]  

  • 20. The antagonism of prostaglandins I2, E1 and D2 by prostaglandin E2 in human platelets.
    Bonne C; Martin B; Watada M; Regnault F
    Thromb Res; 1981 Jan 1-15; 21(1-2):13-22. PubMed ID: 6262942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.